FDA approves generic copy of Remeron anti-depressant

12/19/2003 | Forbes

Barr Laboratories announced the FDA approved its generic version of Akzo Nobel's Remeron, a drug to treat depression. With the approval, Barr has exclusive rights to sell its Soltab in the U.S. for the next six months.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC